Analyst consensus rating
Forte Biosciences Analyst Rating: Hold
FBRX is rated Hold by 5 analysts with a $73.80 target. As of 2026-08-18.
Direct answer
Forte Biosciences's consensus rating is Hold.
5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $73.80.
Forecast evidence checked August 18, 2026.
Get free Forte Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $76.89
- Average price target
- $73.80
- High price target
- $77.00
- Low price target
- $61.00
- Low target gap
- -20.7%
- Target upside
- -4%
- High target gap
- +0.1%
- Target range width
- 20.8%
- Consensus rating
- Hold
- Analysts
- 5
- Evidence date
- August 18, 2026
- Valid through
- August 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Forte Biosciences?
Forte Biosciences has a verified Hold consensus. The same dataset has an average price target of $73.80.
How far are Forte Biosciences's low and high targets from the recorded price?
The low target implies -20.7%, while the high target implies +0.1%.
How many analysts are included in Forte Biosciences's consensus?
The verified consensus includes 5 analysts.
How is Forte Biosciences's target upside or downside calculated?
The average target of $73.80 is divided by the recorded price of $76.89, then one is subtracted to produce -4%. This does not guarantee a future return.
When was Forte Biosciences's analyst forecast verified?
The data was verified on 2026-08-18. The dataset is valid through 2026-08-25.